Improving the value and interpretation of observational studies comparing treatment effects of osteoporosis medications depends on standardized reporting of methods.

Hayes, Kaleen N; Oganisian, Arman; Kiel, Douglas P

Hayes, Kaleen N; Oganisian, Arman; Kiel, Douglas P.

Afiliação

Hayes KN; Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI 02903, United States.
Oganisian A; Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI 02908, United States.
Kiel DP; Department of Biostatistics, Brown University School of Public Health, Providence, RI 02903, United States.

J Bone Miner Res ; 39(7): 807-809, 2024 Aug 05.

Article em En | MEDLINE | ID: mdl-39068509

Assuntos

Estudos Observacionais como Assunto; Osteoporose; Humanos; Osteoporose/tratamento farmacológico; Resultado do Tratamento; Conservadores da Densidade Óssea/uso terapêutico

Palavras-chave

bisphosphonates; denosumab; osteoporosis; pharmacoepidemiology; research methodology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Estudos Observacionais como Assunto Limite: Humans Idioma: En Revista: J Bone Miner Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google